Search Icon
Search Icon
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Maternal & Public HealthAbortion Medical Research Archives

Is Induced Abortion Evidence-Based Medical Practice?

Abstract

Leaders of medical schools and health professional associations in the United States have affirmed their commitment to induced abortion by persistently asserting that the procedure is evidence-based medical practice. There is an objective structured process by which the status of “evidence-based” is attained. It requires a detailed description and documentation of the patient’s disease, illness or condition; an explanation for how the treatment intervention ameliorates the problem; the outcomes by which the effectiveness of the treatment is measured; and the comparison of the treatment with other alternative interventions available. We provide historical context which indicates that staunch abortion advocate thought leaders considered the right to abortion on demand to be inconsistent with the concept of evidence-based practice. We summarize the research on the reasons why women choose abortion, and we review the questions, designs and findings available in the relevant Cochrane Library systematic reviews. Our conclusion is that the quality of abortion science in general is quite weak, that the data necessary for valid research is scarce, and that the claims of evidence-based induced abortion are unsupported by the existing body of published knowledge.

Read Complete Article

Latest Posts

October 6, 2026 A magnifying glass rests on three wooden blocks that spell out FDA, symbolizing a review of the REMS modification. A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review October 6, 2026 Ultrasound image showing the side profile of a human baby Inside The Government Decision That Opened Up Abortion Pill Floodgates October 6, 2026 A sign for the FDA featuring the agency’s logo and circular seals in front of a brick government building, where clinical guidance for mifepristone REMS is often determined. Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone

You Might Also Be Interested In

Abortion Reporting: Kentucky (2025)

Abortion Reporting: Alabama (2025)

Abortion Reporting: Virginia (2024)

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image